Cytokinetics CYTK Payments for finance leases
Payments for finance leases at other companies
Other financials
Where this comes from
Reported directly by Cytokinetics in its filing.
Tagged under the XBRL concept us-gaap:FinanceLeasePrincipalPayments.
The official record: Cytokinetics’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Cytokinetics's payments for finance leases.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Cytokinetics's payments for finance leases?
- Cytokinetics (CYTK) reported payments for finance leases of $0 in Q1 2026.
- How has Cytokinetics's payments for finance leases changed year-over-year?
- Cytokinetics's payments for finance leases decreased by 100.0% year-over-year, from $202K to $0.
- What does payments for finance leases mean?
- The principal cash payments made for leased assets.
- How do you interpret payments for finance leases?
- Higher payments indicate a larger debt-like obligation for leased assets, while lower payments suggest reduced reliance on financed assets.
- How does payments for finance leases compare across companies?
- Standard across industries; reflects the company's preference for leasing versus owning critical infrastructure.